Lifemd Inc Stock Market Capitalization
| LFMD Stock | USD 9.94 0.47 4.51% |
Fundamental analysis of LifeMD allows traders to better anticipate movements in LifeMD's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. LifeMD Inc Company Market Capitalization Analysis
LifeMD's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current LifeMD Market Capitalization | 451.75 M |
Most of LifeMD's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LifeMD Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of LifeMD Inc is about 451.75 M. This is 96.51% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The market capitalization for all United States stocks is 97.63% higher than that of the company.
LifeMD Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LifeMD's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LifeMD could also be used in its relative valuation, which is a method of valuing LifeMD by comparing valuation metrics of similar companies.LifeMD is currently under evaluation in market capitalization category among its peers.
LifeMD Fundamentals
| Return On Equity | -22.43 | ||||
| Return On Asset | -0.0688 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 442 M | ||||
| Shares Outstanding | 45.45 M | ||||
| Shares Owned By Insiders | 16.57 % | ||||
| Shares Owned By Institutions | 37.84 % | ||||
| Number Of Shares Shorted | 4.34 M | ||||
| Price To Book | 107.72 X | ||||
| Price To Sales | 1.93 X | ||||
| Revenue | 212.45 M | ||||
| Gross Profit | 205.9 M | ||||
| EBITDA | (6.65 M) | ||||
| Net Income | (18.88 M) | ||||
| Cash And Equivalents | 5.84 M | ||||
| Cash Per Share | 0.19 X | ||||
| Total Debt | 25.1 M | ||||
| Debt To Equity | 0.46 % | ||||
| Current Ratio | 0.52 X | ||||
| Book Value Per Share | (0.05) X | ||||
| Cash Flow From Operations | 17.51 M | ||||
| Short Ratio | 2.37 X | ||||
| Earnings Per Share | (0.33) X | ||||
| Target Price | 14.0 | ||||
| Number Of Employees | 304 | ||||
| Beta | 2.41 | ||||
| Market Capitalization | 451.75 M | ||||
| Total Asset | 72.46 M | ||||
| Retained Earnings | (236.25 T) | ||||
| Working Capital | (11.52 M) | ||||
| Net Asset | 72.46 M |
About LifeMD Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LifeMD Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LifeMD using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LifeMD Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:Check out LifeMD Piotroski F Score and LifeMD Altman Z Score analysis. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.